| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphoprotein binding | 9.31e-04 | 117 | 8 | 2 | GO:0051219 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 4.47e-06 | 79 | 9 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion mediated by integrin | 2.05e-04 | 50 | 9 | 2 | GO:0033628 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 2.86e-04 | 59 | 9 | 2 | GO:0000381 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.03e-04 | 358 | 9 | 3 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.03e-04 | 358 | 9 | 3 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.16e-04 | 362 | 9 | 3 | GO:0000375 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 6.79e-04 | 91 | 9 | 2 | GO:0033627 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.08e-03 | 502 | 9 | 3 | GO:0008380 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.36e-03 | 129 | 9 | 2 | GO:0048024 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.41e-03 | 551 | 9 | 3 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.03e-03 | 158 | 9 | 2 | GO:0050684 | |
| Domain | RCC1 | 3.90e-05 | 20 | 9 | 2 | PF00415 | |
| Domain | RCC1_1 | 4.31e-05 | 21 | 9 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.31e-05 | 21 | 9 | 2 | PS00626 | |
| Domain | RCC1_3 | 4.31e-05 | 21 | 9 | 2 | PS50012 | |
| Domain | Reg_chr_condens | 4.74e-05 | 22 | 9 | 2 | IPR000408 | |
| Domain | - | 4.74e-05 | 22 | 9 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 5.19e-05 | 23 | 9 | 2 | IPR009091 | |
| Domain | BTB | 1.70e-03 | 131 | 9 | 2 | PF00651 | |
| Domain | BTB | 2.52e-03 | 160 | 9 | 2 | PS50097 | |
| Domain | BTB | 3.18e-03 | 180 | 9 | 2 | SM00225 | |
| Domain | BTB/POZ_dom | 3.36e-03 | 185 | 9 | 2 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 3.50e-03 | 189 | 9 | 2 | IPR011333 | |
| Pubmed | Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients. | 5.95e-08 | 2 | 9 | 2 | 38679985 | |
| Pubmed | 7.13e-06 | 16 | 9 | 2 | 19256485 | ||
| Pubmed | 2.78e-05 | 244 | 9 | 3 | 29884807 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 3.28e-05 | 258 | 9 | 3 | 37794589 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.31e-04 | 411 | 9 | 3 | 35182466 | |
| Pubmed | 1.40e-04 | 421 | 9 | 3 | 34650049 | ||
| Pubmed | 1.51e-04 | 72 | 9 | 2 | 33106477 | ||
| Pubmed | 2.20e-04 | 87 | 9 | 2 | 37495603 | ||
| Interaction | NUDCD2 interactions | 2.24e-05 | 424 | 9 | 4 | int:NUDCD2 | |
| Interaction | PPHLN1 interactions | 3.03e-05 | 146 | 9 | 3 | int:PPHLN1 | |
| Interaction | RCBTB1 interactions | 3.71e-05 | 21 | 9 | 2 | int:RCBTB1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q14 | 9.88e-04 | 244 | 9 | 2 | chr13q14 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.37e-04 | 134 | 5 | 2 | 861 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.77e-05 | 519 | 9 | 4 | M3395 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 2.11e-05 | 543 | 9 | 4 | MM997 | |
| Coexpression | GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.50e-05 | 199 | 9 | 3 | M9168 | |
| Coexpression | TCGA_GLIOBLASTOMA_COPY_NUMBER_DN | 4.85e-05 | 31 | 9 | 2 | M5520 | |
| Coexpression | GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP | 8.72e-04 | 131 | 9 | 2 | M8933 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP | 1.46e-03 | 170 | 9 | 2 | M40872 | |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 1.48e-03 | 171 | 9 | 2 | M7105 | |
| Coexpression | GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN | 1.53e-03 | 174 | 9 | 2 | M8931 | |
| Coexpression | GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN | 1.62e-03 | 179 | 9 | 2 | M5664 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN | 1.78e-03 | 188 | 9 | 2 | M40862 | |
| Coexpression | HOXA9_DN.V1_UP | 1.86e-03 | 192 | 9 | 2 | M2850 | |
| Coexpression | GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN | 1.95e-03 | 197 | 9 | 2 | M9879 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 1.95e-03 | 197 | 9 | 2 | M8271 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 1.95e-03 | 197 | 9 | 2 | M9862 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 1.97e-03 | 198 | 9 | 2 | M2077 | |
| Coexpression | GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN | 1.97e-03 | 198 | 9 | 2 | M9800 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP | 1.97e-03 | 198 | 9 | 2 | M5015 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 1.99e-03 | 199 | 9 | 2 | M4494 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_UP | 1.99e-03 | 199 | 9 | 2 | M7784 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 1.99e-03 | 199 | 9 | 2 | M5970 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_DN | 1.99e-03 | 199 | 9 | 2 | M3813 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN | 1.99e-03 | 199 | 9 | 2 | M9170 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 1.99e-03 | 199 | 9 | 2 | M9523 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN | 1.99e-03 | 199 | 9 | 2 | M9323 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.99e-03 | 199 | 9 | 2 | M5201 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN | 1.99e-03 | 199 | 9 | 2 | M8707 | |
| Coexpression | GSE10325_CD4_TCELL_VS_BCELL_UP | 1.99e-03 | 199 | 9 | 2 | M3076 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 1.99e-03 | 199 | 9 | 2 | M6108 | |
| Coexpression | GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN | 2.01e-03 | 200 | 9 | 2 | M7065 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M7457 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP | 2.01e-03 | 200 | 9 | 2 | M5066 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M9467 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP | 2.01e-03 | 200 | 9 | 2 | M6415 | |
| Coexpression | GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M293 | |
| Coexpression | GSE14308_TH1_VS_TH17_UP | 2.01e-03 | 200 | 9 | 2 | M3371 | |
| Coexpression | GSE3039_NKT_CELL_VS_B2_BCELL_UP | 2.01e-03 | 200 | 9 | 2 | M6435 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | 2.01e-03 | 200 | 9 | 2 | M8608 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP | 2.01e-03 | 200 | 9 | 2 | M7304 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 2.01e-03 | 200 | 9 | 2 | M8403 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_UP | 2.01e-03 | 200 | 9 | 2 | M4868 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_DN | 2.01e-03 | 200 | 9 | 2 | M5738 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M5529 | |
| Coexpression | GSE7852_TREG_VS_TCONV_DN | 2.01e-03 | 200 | 9 | 2 | M5752 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 2.01e-03 | 200 | 9 | 2 | M6609 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_UP | 2.01e-03 | 200 | 9 | 2 | M8060 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M8048 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3880 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_DN | 2.01e-03 | 200 | 9 | 2 | M5176 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 2.01e-03 | 200 | 9 | 2 | M9327 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M2936 | |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M7372 | |
| Coexpression | GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M7370 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP | 2.01e-03 | 200 | 9 | 2 | M2929 | |
| Coexpression | GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M7155 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | 2.01e-03 | 200 | 9 | 2 | M5675 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN | 2.01e-03 | 200 | 9 | 2 | M9827 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP | 2.01e-03 | 200 | 9 | 2 | M6944 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M4327 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 2.09e-03 | 204 | 9 | 2 | M10688 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 2.22e-03 | 210 | 9 | 2 | MM1172 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 2.58e-03 | 227 | 9 | 2 | M11234 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN | 2.95e-03 | 243 | 9 | 2 | M41178 | |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 8.96e-06 | 354 | 9 | 4 | GSM605753_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 9.28e-05 | 224 | 9 | 3 | GSM403994_500 | |
| CoexpressionAtlas | CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2 | 1.80e-04 | 280 | 9 | 3 | GSM404003_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | 2.27e-04 | 303 | 9 | 3 | GSM538398_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 2.84e-04 | 327 | 9 | 3 | GSM538380_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3 | 2.94e-04 | 331 | 9 | 3 | GSM538329_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d-tetramer CD4, Spleen, avg-2 | 2.99e-04 | 333 | 9 | 3 | GSM538323_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 3.02e-04 | 334 | 9 | 3 | GSM538406_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3 | 3.05e-04 | 335 | 9 | 3 | GSM605770_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 3.07e-04 | 336 | 9 | 3 | GSM538413_500 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 3.13e-04 | 338 | 9 | 3 | GSM403987_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | 3.13e-04 | 338 | 9 | 3 | GSM605763_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.Sp, 4+ 8- 25- 62Lhi 44lo, Spleen, avg-4 | 3.15e-04 | 339 | 9 | 3 | GSM538382_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d tetramer CD4, Spleen, avg-1 | 3.38e-04 | 347 | 9 | 3 | GSM538322_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4 | 3.46e-04 | 350 | 9 | 3 | GSM538318_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 3.49e-04 | 351 | 9 | 3 | GSM538325_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 3.64e-04 | 356 | 9 | 3 | GSM538409_500 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 3.70e-04 | 358 | 9 | 3 | GSM605909_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3 | 3.89e-04 | 364 | 9 | 3 | GSM605766_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3 | 3.92e-04 | 365 | 9 | 3 | GSM399370_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1+.Th, aGC CD1d tet CD3e CD44 NK1.1, Thymus, avg-3 | 4.58e-04 | 385 | 9 | 3 | GSM538332_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.act.IEL, CD8a+ CD8b- TCRd+ Vg5- CD44hi, Small Intestine, avg-3 | 5.20e-04 | 402 | 9 | 3 | GSM605808_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.act.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44hi, Small Intestine, avg-3 | 5.51e-04 | 410 | 9 | 3 | GSM605802_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 1.88e-03 | 1414 | 9 | 4 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.99e-03 | 161 | 9 | 2 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 2.11e-03 | 1459 | 9 | 4 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.47e-03 | 180 | 9 | 2 | JC_iEC_1000_K2 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 169 | 9 | 3 | 18ba8fc2ba8838484d3b223428cd41568e2ccb10 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 169 | 9 | 3 | 47a63afd80cb7ba2258ba57d3084d8b2a7bc4e8d | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.61e-06 | 173 | 9 | 3 | 42272af45547422ef85e35f4a4c7d269e9ed7a8a | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-06 | 174 | 9 | 3 | 5c69447261c5aa309a24882656da90655728d637 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-06 | 181 | 9 | 3 | ee1c5af8ed75dd8a0ed3152ba5b9a42d2a8c2ae4 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-06 | 189 | 9 | 3 | 159b0979c93b7d98aaeeb43fba5983a9f67b9c9d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 113 | 9 | 2 | 91e73e3b93be242fef0f14eddd8085a1f1c730ef | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 113 | 9 | 2 | 357bc20edc5bc14eab8262d52260ed1686e9dc54 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.30e-04 | 115 | 9 | 2 | 207d464c09caf9be361daa56c83cd7da5cf9ce47 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.07e-04 | 153 | 9 | 2 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-04 | 154 | 9 | 2 | d2aa24c593a1c0c6f186b74a18438b64b4e59701 | |
| ToppCell | COVID-19-kidney-Mito-rich_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.12e-04 | 154 | 9 | 2 | b437acc11e35fe05389e552d507f6f76e20cc102 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 158 | 9 | 2 | 8844fba9c1e41f062edf3110d025f33b86afb951 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 158 | 9 | 2 | c56607cba9a3719ac6d573d970686053e1676985 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-04 | 160 | 9 | 2 | 0a507e3d59d7f744d0201a531ea84fa97a68aedb | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-04 | 160 | 9 | 2 | e4516b093003275084fc327d1597394a436754eb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-04 | 161 | 9 | 2 | 54eda81a570e422b35fcea799e640c7654122969 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.51e-04 | 161 | 9 | 2 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 162 | 9 | 2 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 162 | 9 | 2 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.56e-04 | 162 | 9 | 2 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-04 | 162 | 9 | 2 | f0a92c92c3a6cf9fa11fb279a584e7f328cb7d43 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-04 | 162 | 9 | 2 | 04ccd3d216f8f41afd3434a61264f03d6324db35 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-04 | 164 | 9 | 2 | e9e34c305c943675688e54ab331c2bdefb2fac68 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 166 | 9 | 2 | dbb73742db00982539b1800aef8af2801b3a0598 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 166 | 9 | 2 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-04 | 166 | 9 | 2 | 62523e635784512b3261b672beaa7747cb9d114a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 166 | 9 | 2 | b7027802cac6ebf3c4a19ef11c9164d92694a4eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 167 | 9 | 2 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-04 | 168 | 9 | 2 | 2765d98f0b7f6861d662937535e051d41dba3500 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 169 | 9 | 2 | 3e608377b57e7f309d243467668c50abb499fcfe | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-04 | 169 | 9 | 2 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 169 | 9 | 2 | 2ad6ab74788c8738c9087811688a6128e5fa882a | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.96e-04 | 169 | 9 | 2 | ad9054ee09033b648a76baf1b2ec4a6ab1394bde | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 4.96e-04 | 169 | 9 | 2 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 4.96e-04 | 169 | 9 | 2 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-04 | 169 | 9 | 2 | 1de3ae36d3b60e961bfd9f7bdc37867b82a0417f | |
| ToppCell | droplet-Marrow-BM-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 169 | 9 | 2 | 8e7a30eb546fc6fa184ebb76f54b74b278005a84 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-04 | 170 | 9 | 2 | c1f7f1bb8865e954bb499963d82bb51923d5d8d6 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 5.02e-04 | 170 | 9 | 2 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.02e-04 | 170 | 9 | 2 | 282afbbea5c88d973cf44727c473a3615f0f02a3 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 5.02e-04 | 170 | 9 | 2 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | a3bcf0d432d8fccce50248e8d0c7a4804d69bfee | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | 976d27edd5608616830624907fe050fcd3551865 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-04 | 173 | 9 | 2 | 6397b3fa72e2621a9a0f27f49446de2d3a30e420 | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 5.26e-04 | 174 | 9 | 2 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-04 | 175 | 9 | 2 | 9a462e9e6f7bbb64abb09ad6c080df3576073540 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-04 | 175 | 9 | 2 | a72c6ceca5ddbd34f652e7302defefa2d105e17e | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-04 | 176 | 9 | 2 | 0823088bc6b19c7ad784d83c2ccdfae80611afab | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-04 | 176 | 9 | 2 | 9c0fb2c6ae84febdf7c3d4e648985f597dcffe7a | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-04 | 176 | 9 | 2 | 3d372c1d527fcc118d1e5809f2524fc387682472 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-04 | 176 | 9 | 2 | 7b3f3d9b33770edf294cee0eccaf8a46f9331461 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-04 | 176 | 9 | 2 | 77c6103639acd0f3d6a2171c5f37a8083b6c2cf0 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-04 | 176 | 9 | 2 | 2e3f25a338842384517656d05776a52cbfc62b52 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.44e-04 | 177 | 9 | 2 | e1ba7e17af2c54d3c78cdf85882168c5b896e453 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 177 | 9 | 2 | b7cfa3776f58377e35830780650d236b5cceecee | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | 6561794ae3b14b5279b249eb5e93b80ef15ed82c | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | 9a5bf67a801826d094f679dd2189b62296c9694f | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 177 | 9 | 2 | 1730e640986e50943bd781b7d949bcc5b7c12dde | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | 7853430fb0d1a18d835e8956777e0616c5d7d412 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 177 | 9 | 2 | d6b7d387e7485ff52ce27f51df8b8050f49fd941 | |
| ToppCell | facs-Skin-Anagen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 177 | 9 | 2 | 395f005f019aabb18738d3a10a04c37f216deda3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 177 | 9 | 2 | 44c38e572a9e9678c2dbb3e8b4748e7e28d404b7 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 7c101e3957ea9b0d4ebf619d1d02e7e64ae28915 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-04 | 178 | 9 | 2 | 5101a45595cd8d702f911afadf1eb0ee10bdcefc | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-04 | 178 | 9 | 2 | f52f837e948deb6a2d031325f49891bca8d375da | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.50e-04 | 178 | 9 | 2 | 28bb1e3e447261d0cb47e2b6343b17b2d74db525 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-04 | 178 | 9 | 2 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-04 | 179 | 9 | 2 | ac0c257e63a5994282d8b350c1b517cc3fbee52a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 179 | 9 | 2 | 8bf04a7ad1b0be6722ebfdceba3f083f07bf96c5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 179 | 9 | 2 | 30efe1f0394c0edb27b91890b5c4637b73cbc5ec | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-04 | 180 | 9 | 2 | f3f7a610db750fcb84d746a5ea0d8b57f9b7d901 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.63e-04 | 180 | 9 | 2 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.63e-04 | 180 | 9 | 2 | d6e69ac2bd619557ef62ada684c37a44dc4e3f41 | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-04 | 180 | 9 | 2 | bb2f1b254371924b2045e9e1a81b6dbf4f00dd6a | |
| ToppCell | COVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations) | 5.69e-04 | 181 | 9 | 2 | 534659cf754326c6a73c0daa30e9d610612a0292 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | be7c7db6b99603759593e6f79cdcaa4bbf234cb7 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-04 | 181 | 9 | 2 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 5.75e-04 | 182 | 9 | 2 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.81e-04 | 183 | 9 | 2 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-04 | 183 | 9 | 2 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.81e-04 | 183 | 9 | 2 | c9cb69377883d4579c608ec8b265153fe5290e67 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-04 | 183 | 9 | 2 | 450c30d2e389fcb17825394c27f9ccc4f33022e3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.88e-04 | 184 | 9 | 2 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 8fa7aa2a954f66576ada56670b4e1bb122864761 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 5cf7447faaec99fc37dfa8e92ff72cc2c7c05951 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 7126261a453c7e2f3f005016873b6adeb51e46f8 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | cdacb61878e0824b8416bf365d89965797208359 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | b5fbfcf8516c2dc20dffc36803692505a63f1297 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | b12fb85a064f715a4f0ada1df8e422c359b573cf | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-04 | 185 | 9 | 2 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | 4.28e-05 | 185 | 9 | 3 | 2927_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 4.78e-05 | 192 | 9 | 3 | 4746_DN | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.85e-05 | 193 | 9 | 3 | 5421_UP | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 4.93e-05 | 194 | 9 | 3 | 2284_DN | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; HL60; HG-U133A | 5.08e-05 | 196 | 9 | 3 | 1995_UP | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 9 | 3 | 5005_DN | |
| Drug | 5155877; Down 200; 10uM; MCF7; HT_HG-U133A | 5.16e-05 | 197 | 9 | 3 | 6549_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 5.16e-05 | 197 | 9 | 3 | 1441_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; PC3; HT_HG-U133A | 5.24e-05 | 198 | 9 | 3 | 7272_DN | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; HL60; HG-U133A | 5.24e-05 | 198 | 9 | 3 | 1611_UP | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 5.31e-05 | 199 | 9 | 3 | 2822_UP | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; HL60; HG-U133A | 5.31e-05 | 199 | 9 | 3 | 1600_UP | |
| Drug | BT-B | 9.62e-05 | 243 | 9 | 3 | CID000081462 | |
| Drug | OL-P | 3.21e-04 | 69 | 9 | 2 | CID000002856 | |
| Drug | tetrahydro-beta-carboline-3-carboxylic acid | 1.12e-03 | 129 | 9 | 2 | CID000098285 | |
| Drug | P-NE | 1.91e-03 | 169 | 9 | 2 | CID000446755 | |
| Drug | daunorubicin HCl; Up 200; 1uM; MCF7; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 7525_UP | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.16e-03 | 180 | 9 | 2 | 2859_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; HL60; HT_HG-U133A | 2.18e-03 | 181 | 9 | 2 | 2378_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.20e-03 | 182 | 9 | 2 | 947_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.23e-03 | 183 | 9 | 2 | 7136_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 2.23e-03 | 183 | 9 | 2 | 7088_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; HL60; HG-U133A | 2.28e-03 | 185 | 9 | 2 | 1567_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 3278_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 2896_DN | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; HL60; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 2344_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; HL60; HG-U133A | 2.35e-03 | 188 | 9 | 2 | 2000_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.37e-03 | 189 | 9 | 2 | 5254_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 7145_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 6945_DN | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 2920_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 2869_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 3905_UP | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A | 2.42e-03 | 191 | 9 | 2 | 2041_UP | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 7397_DN | |
| Drug | Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; HL60; HG-U133A | 2.42e-03 | 191 | 9 | 2 | 1563_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 5206_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 2831_UP | |
| Drug | Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 3179_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4431_UP | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 3242_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 5965_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 5291_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4113_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1657_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1155_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 5256_DN | |
| Disease | apolipoprotein B measurement | 1.29e-02 | 663 | 8 | 2 | EFO_0004615 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVYGWGYNGNGQLGL | 201 | Q8NDN9 | |
| VYVWGYNGNGQLGLG | 226 | O95199 | |
| GRFNNPGWFRGYRTQ | 36 | Q5BN46 | |
| QWYKPHYQNSGGGNG | 336 | Q13370 | |
| RAYGQQYWGQPGNRG | 671 | Q1KMD3 | |
| QYWGQPGNRGGYRNF | 676 | Q1KMD3 | |
| RYPGGSWGNINRYPG | 266 | Q6UXA7 | |
| FRGRNRGFYPWGQYN | 86 | Q9Y2W1 | |
| RGFYPWGQYNRGGYG | 91 | Q9Y2W1 | |
| WGQYNRGGYGNYRSN | 96 | Q9Y2W1 | |
| RGGYGNYRSNWQNYR | 101 | Q9Y2W1 | |
| RYYWDFQPQGGDIGQ | 51 | Q86WV1 | |
| QQNQIGYPQPYGQWG | 296 | P31483 | |
| GYPQPYGQWGQWYGN | 301 | P31483 |